WNT2B and head and neck squamous cell carcinoma: Indeed, our detailed clinical investigations demonstrated significantly elevated levels of Wnt2B (Fig. 4h) and its potential to independently predict clinical outcomes in HNSCC patients (Fig. 4i and Fig. S4H).